CVE-2026-14996: IBM Aspera Faspex 5 · Insufficient Session Expiration
Affects IBM Aspera Faspex 5Source CVE Database V5
Not known to be exploited · CVSS 8.2 High.
Data as of 27 Oct 2026, 17:11 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 26% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 28 Jul 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMAspera Faspex 5 | Affected
| Fixed in– |
CPE configurations (2)
cpe:2.3:a:ibm:aspera_faspex_5:5.0.0:*:*:*:*:*:*:*cpe:2.3:a:ibm:aspera_faspex_5:5.0.15.4:*:*:*:*:*:*:*
AI-suggested
The description indicates the issue is addressed in versions after 5.0.15.4, so upgrading to a version later than 5.0.15.4 is recommended once official patches or updates are available from IBM. Monitor IBM's official security advisories for updates.
Description
IBM Aspera Faspex 5 versions 5.0.0 through 5.0.15.4 contain a vulnerability related to insufficient session expiration. This weakness can lead to unauthorized access due to sessions not terminating properly. The vulnerability is identified as CWE-613 and has a high severity with a CVSS score of 8.2.